These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 29755478)

  • 1. The Contribution of Autoantibodies to Inflammatory Cardiovascular Pathology.
    Meier LA; Binstadt BA
    Front Immunol; 2018; 9():911. PubMed ID: 29755478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.
    Gounopoulos P; Merki E; Hansen LF; Choi SH; Tsimikas S
    Minerva Cardioangiol; 2007 Dec; 55(6):821-37. PubMed ID: 18091649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmunity, oxidized LDL and cardiovascular disease.
    Frostegård J
    Autoimmun Rev; 2002 Aug; 1(4):233-7. PubMed ID: 12849001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence on the pathogenic role of auto-antibodies in acute cardiovascular diseases.
    Carbone F; Nencioni A; Mach F; Vuilleumier N; Montecucco F
    Thromb Haemost; 2013 May; 109(5):854-68. PubMed ID: 23446994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is preclinical autoimmunity benign?: The case of cardiovascular disease.
    Majka DS; Chang RW
    Rheum Dis Clin North Am; 2014 Nov; 40(4):659-68. PubMed ID: 25437283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Auto-antibodies as possible markers and mediators of ischemic, dilated, and rhythmic cardiopathies.
    Satta N; Vuilleumier N
    Curr Drug Targets; 2015; 16(4):342-60. PubMed ID: 25429713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of β₁-adrenoceptor autoantibodies in the pathogenesis of dilated cardiomyopathy.
    Dandel M; Wallukat G; Potapov E; Hetzer R
    Immunobiology; 2012 May; 217(5):511-20. PubMed ID: 21820755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-heart autoantibodies in familial dilated cardiomyopathy.
    Caforio AL; Vinci A; Iliceto S
    Autoimmunity; 2008 Sep; 41(6):462-9. PubMed ID: 18781472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atherosclerosis and autoimmunity: a growing relationship.
    Sanjadi M; Rezvanie Sichanie Z; Totonchi H; Karami J; Rezaei R; Aslani S
    Int J Rheum Dis; 2018 May; 21(5):908-921. PubMed ID: 29671956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulation of vascular diseases: atherosclerosis and autoimmunity.
    Shi GP
    Eur J Vasc Endovasc Surg; 2010 Apr; 39(4):485-94. PubMed ID: 20188603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral Immunity Against HDL Particle: A New Perspective in Cardiovascular Diseases?
    Satta N; Frias MA; Vuilleumier N; Pagano S
    Curr Pharm Des; 2019; 25(29):3128-3146. PubMed ID: 31470782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies and cardiovascular dysfunction: cause or consequence?
    Nagatomo Y; Tang WH
    Curr Heart Fail Rep; 2014 Dec; 11(4):500-8. PubMed ID: 25142807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aptamer neutralization of beta1-adrenoceptor autoantibodies isolated from patients with cardiomyopathies.
    Haberland A; Wallukat G; Dahmen C; Kage A; Schimke I
    Circ Res; 2011 Oct; 109(9):986-92. PubMed ID: 21868696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasoactive Intestinal Peptide Ameliorates Acute Myocarditis and Atherosclerosis by Regulating Inflammatory and Autoimmune Responses.
    Benitez R; Delgado-Maroto V; Caro M; Forte-Lago I; Duran-Prado M; O'Valle F; Lichtman AH; Gonzalez-Rey E; Delgado M
    J Immunol; 2018 Jun; 200(11):3697-3710. PubMed ID: 29669783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial injury due to G-protein coupled receptor-autoimmunity.
    Matsui S; Fu ML
    Jpn Heart J; 1998 May; 39(3):261-74. PubMed ID: 9711178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerogenic vaccines for the treatment of cardiovascular diseases.
    Vigario FL; Kuiper J; Slütter B
    EBioMedicine; 2020 Jul; 57():102827. PubMed ID: 32574952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive and protective autoimmunity in cardiovascular diseases: is vaccination therapy a reality?
    Toubi E; Shoenfeld Y
    Lupus; 2005; 14(9):665-9. PubMed ID: 16218463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-M2 muscarinic receptor autoantibodies and idiopathic dilated cardiomyopathy.
    Fu ML
    Int J Cardiol; 1996 May; 54(2):127-35. PubMed ID: 8803676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac beta1-adrenoceptor autoantibodies in human heart disease: rationale and design of the Etiology, Titre-Course, and Survival (ETiCS) Study.
    Deubner N; Berliner D; Schlipp A; Gelbrich G; Caforio AL; Felix SB; Fu M; Katus H; Angermann CE; Lohse MJ; Ertl G; Störk S; Jahns R;
    Eur J Heart Fail; 2010 Jul; 12(7):753-62. PubMed ID: 20494925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular and oral disease interactions: what is the evidence?
    Ford PJ; Yamazaki K; Seymour GJ
    Prim Dent Care; 2007 Apr; 14(2):59-66. PubMed ID: 17462139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.